Villamor, Erlinda N.
HRN: 20-49-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
LEVOFLOXACIN 500MG (TAB)
06/22/2022
06/29/2022
ORAL
750mg
OD
Septicemia
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaSkin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes